This product is eligible for VAT relief

VAT on this product will be charged at 0% if VAT relief is claimed at the final stage of the checkout process. Please be aware VAT will show at 20% until that point. Full details can be found here and at the checkout.

Trustpilot
View reviews

Oniris Clinically Proven Mandibular Advancement Device from Oniris

SKUOniris

Oniris is the leading off-the-shelf mandibular device for snoring and Sleep Apnoea, clinically proven to be as effective as a custom-made oral appliance.
The unique design provides an impression equivalent to laboratory-produced mouthpieces while allowing millimetre-precise adjustment and freedom to talk and drink naturally.
The Oniris device is the only self-adjustable anti-snoring device whose efficacy has been assessed and proven in hospitals and clinics by sleep and ENT specialists. Each pack contains two sizes, allowing you to try both options and choose the most comfortable for you.

This product is eligible for VAT relief

VAT on this product will be charged at 0% if VAT relief is claimed at the final stage of the checkout process. Please be aware VAT will show at 20% until that point. Full details can be found here and at the checkout.

£119.00with VAT Relief

In Stock

Innovative and Patented

Oniris is an innovative and patented Mandibular Advancement Device (MAD) designed to provide maximum levels of comfort and efficacy. The device is similar to a mouthguard for sportsmen or a dental splint and gently retains your lower jaw in a forward position during sleep. Once in place, the device allows air to pass freely through the throat, preventing the obstructions that cause snoring and Sleep Apnoea.

Numerous clinical studies have shown that this technique works. Oniris is the only solution to offer patients a customised fitting and total freedom of movement for a comfortable and effective adjustment.

In addition, Oniris is the first – and only – thermoplastic (heat and bite) MAD that is non-inferior to custom-made devices1.

 

How it works

Oniris includes two sizes in every pack. It is advised that you start with the small size, and in the event this is too small, try the larger device. Each Oniris MAD has an average lifespan of between 12 and 24 months, making it one of the most cost-effective Sleep Apnoea therapies over its lifespan. The device can also be remoulded up to 5 times – a useful function if you are undergoing dental work.

The device has nine adjustment settings. Starting with 0 – when you take the impression. Advancement then starts with position 1. If you are new to mandibular advancement, it is advised that you wear the device for short periods throughout the day before wearing it for a full night of sleep. Your jaw and teeth will need time to adjust, and a slow introduction can reduce the chance of tooth and jaw discomfort.

Once you are happy and comfortable with position 1, you move up to position 2 and so on until you reach a level of advancement which is suitable for you. Advancement options are from 0 to 11mm.

Oniris Mandibular Device | Intus Healthcare

Its patented articulation and propulsion system provides complete freedom of movement, enhancing long-term comfort and adherence to the treatment.

 

Clinically Proven

The Iris Clinical Study is the largest randomised controlled study in the field of Mandibular Advancement Devices and included 200 patients who were all refusing or not tolerating CPAP. These patients had an average AHI of 26.6/h.

  • 1 year of follow-up in 7 different facilities
  • In Intention-To-Treat (ITT) and Per-Protocole (PP) analysis

Objective:
To determine whether Oniris thermoplastic heat-moulded titrable MAD is non-inferior to a custom-made MAD for Obstructive Sleep Apnoea (OSA) in terms of effectiveness, compliance and tolerance.
Results:

  • The non-inferiority of Oniris MAD is confirmed regardless of the analyzed population (ITT or PP),
    gender, BMI or OSA severity.
  • Good or excellent compliance for 89.7% of patients at 2 months and for 93.1% at 12 months.
  • No significant dental or joint impact was observed in more than 96.6% of patients after 1 year
    of treatment.
  • Publication: The results of the IRIS study were published in the scientific journal

 

94 % of users satisfied or very satisfied2
83 % of full efficiency on snoring2
77 % of full efficiency on Sleep Apnoea2

 

Case Study

Habitual snoring occurs in around 44% of males and 28% of females between ages 30 and 60; however, not everyone who snores has a sleeping disorder like Obstructive Sleep Apnoea (OSA).

This device is clinically tested and proven to help reduce or eliminate snoring and can help reduce the symptoms of mild and moderate Sleep Apnoea. We asked a customer whose snoring had progressively worsened over the last six months to document their experience using the Oniris MAD.

Customer Case Study: A personal account using A MAD.

 

Benefits of the Oniris MAD

 

First Line Therapy

  1. Immediate treatment of snoring and suspected Sleep Apnoea whilst waiting for diagnostic examination
  2. Snoring, mild to moderate Sleep Apnoea

Second Line Therapy

  1. In case of CPAP refusal or intolerance
  2. In substitution to CPAP, for short travels or the second part of the night
  3. To determine whether mandibular advancement therapy is feasible and effective before ordering a custom-made MAD for long-term use

 

 

Intus Healthcare the Sleep Apnoea specialists ✔ Stop snoring over the long term

✔ Treat your Sleep Apnoea

✔ Improve your health by reducing the impacts of snoring and Sleep Apnoea

✔ Sleep better and enjoy refreshing sleep

✔ Self-adjusting device for slow introduction and personalised therapy

 

 

 

30-day money-back guarantee

Oniris are so confident in the design and efficacy of this device that you can try it at home for 30 days with a money-back guarantee. From the moment you receive your device, we are here to support you. If you have any questions or need help introducing and getting used to your new oral device, please do not hesitate to contact us. We have a range of video tutorials and tips to help you get the very best from your device.

 

Maintenance

Your Oniris device should be kept in its box at all times and at a temperature below 45C. After each use, brush the device with a toothbrush and toothpaste, then rinse thoroughly with cold water.

It is highly recommended to use effervescent disinfectant tablets to prevent odours and the development of biofilms. Nitradine tablets are great for cleaning and safely disinfecting removable dental appliances, including dentures, orthodontic retainers and bite guards and are clinically proven to be effective against harmful bacteria.

 

References:

1) https://pubmed.ncbi.nlm.nih.gov/31053619/ – Accessed 10/03/2021

2) Marty, M., Lacaze, O., Arreto, C. D., Pierrisnard, L., Bour, F., Chéliout-Héraut, F. and Simonneau, G. (2017), Snoring and Obstructive Sleep Apnea: Objective Effi cacy and Impact of a Chairside Fabricated Mandibular Advancement Device. Journal of Prosthodontics, 26: 381-386. doi:10.1111/jopr.12401

 

Additional information

Weight 250 g
Dimensions 20 × 20 × 20 cm
Manufacturer

Oniris
VAT relief eligible

Yes
Made In

United Kingdom
Condition

New
Warranty

12 Months
CE/UKCA Certified

Yes
Packaged weight

250g
Clinically validated

Yes
Suitable for

Mild to moderate Sleep Apnoea

Back to top

Related Products